Microcrystalline tyrosine(MCT ®): A depot adjuvant in licensed allergy immunotherapy offers new opportunities in Malaria.
G. Cabral-Miranda, et al. Vaccines 2017, 5(4), 32.
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
G. Cabral-Miranda, et al. Vaccines 2017, 5(2), 10
Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza
M.D. Heath, et al. BMC Infectious Diseases (2017) 17:232
Clinical use of adjuvants in allergen immunotherapy
L. Klimek, et al. Expert Review of Clinical Immunology, 2017, 13:6, 599-610
Analysis of aluminium in rat following administration of allergen immunotherapy using either aluminium or microcrystalline-tyrosine-based adjuvants
S. A. McDougall, et al. Bioanalysis (2016) 8(6), 547–556
The adsorption of allergoids and 3-0-desacyl-4'-monophosphoryl lipid A (MPL®) to microcrystalline tyrosine (MCT) in formulations for use in allergy immunotherapy.
A.J. Bell, et al. Journal of Inorganic Biochemistry 152 (2015) 147–153
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
G.Cabral-Miranda, et al. MDPI (2018) 6(4):107
Vaccination with nanoparticles combined with micro adjuvants protects against cancer
M. Mohsen, et al. Journal for Immunotherapy of Cancer (2019) 7:114
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)
M.D. Heath, et al. Frontiers Immunology (2020) 11:594911
Feel free to contact us if you have any questions
Please fill in all the fields
This website uses cookies to ensure you get the best experience on our website.
Click here for more information